CANCER patients have placed information dished out at Doncaster Royal Infirmary as among the poorest in the country, a survey has revealed.
Most of the areas covered by the National Cancer Patient Survey 2010 rated the Doncaster and Bassetlaw Hospitals NHS Trust above average.
But it fell down on its performance on providing patients with some written information, where it was rated among the worst 20 per cent.
The trust was in the lowest 20 per cent in five areas. These were where written information for diagnostics was not easily understood, patients were not given written information about side effects, support groups, or financial help, or the right amount of information about their condition and treatment throughout their NHS care.
But the Trust was rated as average or good in 68 of the 73 areas asked for their opinions – the equivalent of 93 per cent.
There were 12 areas where the Trust’s services were rated better than average, including patients being seen as soon as necessary, patients completely understanding explanations, patients setting understandable answers to important questions, receiving privacy when examined and giving patients understandable explanations of how operations had gone.
Ian Greenwood, director of strategic and service development and the trust’s lead for cancer services, praised staff.
He said: “We provide excellent services for patients with cancer – and now patients have confirmed this in a national survey.
“Clearly, there are some areas where we need to do better. We use this feedback to help us make further improvements.”
There were 158 acute hospital NHS Trusts providing cancer services taking part in the survey.
It included all adult patients with a primary diagnosis of cancer, who had been admitted to an NHS hospital as an inpatient or as a daycase patient, and had been discharged between January 1 and March 31 last year. In the Doncaster area, 522 patients were selected and sent the questionnaire, and 312 of those responded.
The survey findings are being circulated to staff and will be discussed by the trust’s cancer management team.